Preferred Label : lifitegrast;

MeSH note : an LFA-1 antagonist;

CISMeF synonym : SAR 1118;

MeSH synonym : (2S)-2-(((2-(benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinolin-6- yl)carbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid; L-phenylalanine, n-((2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl)-3-(methylsulfonyl)-;

MeSH hyponym : SHP606; SAR-1118;

Is substance : O;

UNII : 038E5L962W;

Details


Main resources

You can consult :


https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00383
2018
false
false
false
Canada
French
English
drug information
lifitegrast
drug evaluation
drug approval
canada
lymphocyte Function-Associated Antigen-1
dry eye syndromes
adult
aged
administration, ophthalmic
ophthalmic solutions
treatment outcome
risk assessment
lifitegrast
product surveillance, postmarketing
lifitegrast
sulfones
phenylalanine
sulfones
phenylalanine
phenylalanine
sulfones
phenylalanine

---
Nous contacter.
02/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.